As the biotechnology industry continues its rapid growth, firms must cultivate a highly skilled workforce dedicated to moving each company forward. Workers are increasingly insisting on job flexibility, creating a challenge for businesses that only desire onsite employees.
Leen Kawas, Ph.D., Propel Bio Partners’ Managing General Partner, presented a solution in an April 2023 Forbes Business Council post. Dr. Kawas emphasized that a hybrid work model can help create balance while enabling employees to deliver excellent performance.